Literature DB >> 17873316

Letter to editor. Re: "Effect of concomitant use of pentoxifylline (PTX) and alpha-tocopherol with radiotherapy on the clinical outcome of patients with stage IIIB non-small cell lung cancer".

Lucy Jellett, Claire Harrison, Jonathan McAleese.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17873316     DOI: 10.1007/s12032-007-0041-9

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


× No keyword cloud information.
  5 in total

1.  Increase in tumor oxygenation and potentiation of radiation effects using pentoxifylline, vinpocetine and ticlopidine hydrochloride.

Authors:  Morikazu Amano; Hajime Monzen; Minoru Suzuki; Kaoru Terai; Satoshi Andoh; Akio Tsumuraya; Takeo Hasegawa
Journal:  J Radiat Res       Date:  2005-12       Impact factor: 2.724

2.  Effect of concomitant use of pentoxifylline and alpha-tocopherol with radiotherapy on the clinical outcome of patients with stage IIIB non-small cell lung cancer: a randomized prospective clinical trial.

Authors:  Cem H Misirlioglu; Handan Erkal; Yesim Elgin; Isil Ugur; Kadri Altundag
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

3.  Effect of pentoxifylline on radiation response of non-small cell lung cancer: a phase III randomized multicenter trial.

Authors:  H C Kwon; S K Kim; W K Chung; M J Cho; J S Kim; J S Kim; S R Moon; W Y Park; S J Ahn; Y K Oh; H G Yun; B S Na
Journal:  Radiother Oncol       Date:  2000-08       Impact factor: 6.280

4.  Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer.

Authors:  Michael P Mac Manus; Rodney J Hicks; Jane P Matthews; Allan McKenzie; Danny Rischin; Eeva K Salminen; David L Ball
Journal:  J Clin Oncol       Date:  2003-04-01       Impact factor: 44.544

5.  Pentoxifylline in prevention of radiation-induced lung toxicity in patients with breast and lung cancer: a double-blind randomized trial.

Authors:  Berrin Ozturk; Ibrahim Egehan; Sevil Atavci; Mehmet Kitapci
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-01-01       Impact factor: 7.038

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.